摘要
一氧化氮(NO),作为一个重要的信号分子,参与诸如心血管稳态、神经传导,免疫调节,和肿瘤的生长等生理过程。因此,不同种类的NO药物包括diazeniumdiolates,S-亚硝基硫醇,亚硝酰,硝基苯等等已经被开发应用。然而,这些低分子量的NO供体已因突发释放,低载荷和无靶点传递问题限制了其临床应用。基于生物材料的载体的NO传递提供了一个有益的策略,实现了NO对靶组织或器官的控制和持续传递。确切来说,通过物理、化学手段或超分子技术,NO供体药物前体已贴装不同的材料来制备纳米颗粒,凝胶,和涂层的平台。这些NO释放的生物材料广泛应用于治疗缺血性疾病、癌症和心血管疾病和伤口愈合的治疗。首先,没有释放的生物材料表面涂层可以模拟血管内皮细胞的生理功能,从而促进血管生成及改善心血管植入物的通畅。其次,因为NO也介导了许多发生在皮肤损伤后的重要过程,无释放的生物材料可以作为理想的伤口敷料,以加速组织再生。最后,生物材料使高剂量的NO传递到肿瘤,从而产生有效的抗肿瘤作用。在这篇综述中,我们将总结不同的NO释放生物材料的进展,并强调他们的生物医学应用,希望能够激发有关生物材料为基础的NO传递系统新的观点。
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
Current Medicinal Chemistry
Title:Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Volume: 23 Issue: 24
Author(s): Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao
Affiliation:
关键词: 一氧化氮,生物材料,控制交货,生物医学应用,心血管疾病,癌症。
摘要: Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterialbased carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
Export Options
About this article
Cite this article as:
Xin Zhou, Jimin Zhang, Guowei Feng, Jie Shen, Deling Kong, Qiang Zhao , Nitric Oxide-Releasing Biomaterials for Biomedical Applications, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160729104647
DOI https://dx.doi.org/10.2174/0929867323666160729104647 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiometabolic Risk Related to the Association of hypertriglyceridemia-Low HDLc
Current Pharmaceutical Design Production and Purification of Functional Lipids Through Enzymatic and Microorganism-Mediated Processes
Current Organic Chemistry The Role of Diet in Patients with Metabolic Syndrome
Current Medicinal Chemistry CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry The Diagnosis of Drug-Induced Liver Disease
Current Clinical Pharmacology Metabolic Therapy of Heart Failure
Current Pharmaceutical Design Access to Medicines and the Safety of the People
Reviews on Recent Clinical Trials Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
Current Drug Discovery Technologies Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Neuro-Psychological Pattern in Patients Suffering from Primitive Dilated Cardiomyopathy with Impairment in Executive Function
Current Neurovascular Research The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner
Anti-Cancer Agents in Medicinal Chemistry Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders
Mini-Reviews in Medicinal Chemistry Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography
Current Medical Imaging Fad Diets: Dietary Dilemmas, Predicaments, and Recommendations for its Use
Current Nutrition & Food Science Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Editorial [ Hot Topic:The Medicinal Chemistry of New Agents to Treat Diabetes and Obesity (Guest Editor: Jie-Fei Cheng)]
Current Topics in Medicinal Chemistry MicroRNA-30 and 145 as Targets for the Treatment of Cardiovascular Diseases: Therapeutic Feasibility and Challenges
Current Pharmaceutical Design Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Current Alzheimer Research Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders: An Update
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued)